FDA inspection

Bloodworks: FDA inspection ending Aug 17, 2017

FDA inspection 1023273 · Voluntary Action Indicated (VAI) · Seattle, WA

Key facts

Inspection ID 1023273
Firm Bloodworks
FEI number 3071347
Address 921 Terry Ave
City Seattle
State WA
ZIP 98104
Country United States
Fiscal year 2017
Inspection end date Aug 17, 2017
Classification Voluntary Action Indicated (VAI)
Project area Human Cellular, Tissue, and Gene Therapies
Product type Biologics

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections